Influences of Shenmai Injection(参麦注射液) on immune functions in patients with respiratory failure
Lin Jian-ha
Abstract
Lin Jian-ha
Abstract
Objective:To investigate the influences of Shenmei Injection (SMI,参麦注射液) on immune functions in patients with respiratory failure.Methods:30 patients were randomly divided into treated group ( n =15 ) and control group ( n =15 ).Based on conventional therapy for both two groups the SMI 40 ml+5% glucose 250 ml infused intravenously once a day was added in treated group.The therapeutic course was 1014 days for two groups.Before and after therapy the T cell subgroup of periferal blood (CD 3,CD 4,CD 8, CD 4/CD 8 ),immune globulin (IgG,IgA,IgM),and soluble interleukin2 receptor (SIL2R) were detected separately in two groups.Results:After therapy in treated group CD 3 and CD 4 were significantly increased while SIL2R was significantly decreased and the decreased level was much more significant than that in control group after therapy.Conclusions:SMI is able to elevate the cellular immune functions in patients with resperatory failure,to help to shorten the ill course,and to improve the prognosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the influences of Shenmei Injection (SMI,参麦注射液) on immune functions in patients with respiratory failure.Methods:30 patients were randomly divided into treated group ( n =15 ) and control group ( n =15 ).Based on conventional therapy for both two groups the SMI 40 ml+5% glucose 250 ml infused intravenously once a day was added in treated group.The therapeutic course was 1014 days for two groups.Before and after therapy the T cell subgroup of periferal blood (CD 3,CD 4,CD 8, CD 4/CD 8 ),immune globulin (IgG,IgA,IgM),and soluble interleukin2 receptor (SIL2R) were detected separately in two groups.Results:After therapy in treated group CD 3 and CD 4 were significantly increased while SIL2R was significantly decreased and the decreased level was much more significant than that in control group after therapy.Conclusions:SMI is able to elevate the cellular immune functions in patients with resperatory failure,to help to shorten the ill course,and to improve the prognosis.
Key concepts: Medicine, Immune system, Internal medicine, Respiratory failure, Respiratory system, Globulin, Gastroenterology, Immunology